UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
[ ] Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue.
1. Name and Address of Reporting Person(s)
Sample, Frank T.
P.O. Box 1070
1400 Shelburne Road
Burlington, VT 05402-1070
2. Issuer Name and Ticker or Trading Symbol
IDX Systems Corporation (IDXC)
3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)
4. Statement for Month/Year
12/97
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
[X] Director [ ] 10% Owner
[X] Officer (give title below) [ ] Other (specify below)
Executive Vice President
7. Individual or Joint/Group Filing (Check Applicable Line)
[X] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
- ------------------------------------------------------------------------------------------------------------------------------------
1)Title of Security 2)Trans- 3.Trans- 4.Securities Acquired(A) 5)Amount of 6) 7)Nature of
action action or Disposed of (D) Securities Indirect
Date Code A Beneficially D Beneficial
(Month/ or Owned at or Ownership
Day/Year) Code V Amount D Price End of Month I
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C><C> <C> <C><C>
Common Stock (1) 12/05/97 M 2,094.00 A D Direct
Common Stock (1) 12/05/97 S (2) 2,094.00 D $31.9411 D Direct
Common Stock (1) 12/05/97 M 14,904.00 A D Direct
Common Stock (1) 12/05/97 S (2) 14,904.00 D $31.9411 36,830.00 D Direct
Common Stock 4,097.00 I By 401(k) Plan
<CAPTION>
Table II (PART 1) Derivative Securities Acquired, Disposed of, or Beneficially Owned (Columns 1 through 6)
- ------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative 2)Conversion 3)Trans- 4)Trans- 5)Number of Derivative 6)Date Exercisable and
Security or Exercise action action Securities Acquired (A) Expiration Date
Price of Date Code or Disposed of (D)
Derivative
Security Code V A D Exercisable Expiration
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Employee Stock Option (right to$23.1900 12/05/97 M 2,094.00 07/10/97 (3) 01/27/05
buy) (1)
Employee Stock Option (right to$23.1900 12/05/97 M 14,904.00 07/10/97 (3) 01/27/05
buy) (1)
<CAPTION>
Table II (PART 2) Derivative Securities Acquired, Disposed of, or Beneficially Owned (Columns 1,3 and 7 through 11)
- ------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative 3)Trans- 7)Title and Amount 8)Price 9)Number of 10) 11)Nature of
Security action of Underlying of Deri- Derivative Indirect
Date Securities vative Securities D Beneficial
Amount or Security Beneficially or Ownership
Number of Owned at I
- Title Shares End of Month
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Employee Stock Option (right to12/05/97 Common Stock (4) 2,094.00 $31.9411 D Direct
buy) (1)
Employee Stock Option (right to12/05/97 Common Stock (4) 14,904.00 $31.9411 1.00 D Direct
buy) (1)
<FN>
Explanation of Responses:
(1)
Prior to the Effective Time of the Merger, the reporting person was a shareholder and optionee of PHAMIS and all of the reporting
person's PHAMIS Common Stock and options for PHAMIS Common Stock have been converted into IDX Common Stock and options for IDX
Common Stock.
(2)
Such shares being sold were acquired in a transaction exempt under Rule 16b-3(d).
(3)
Pursuant to the terms of the Agreement and Plan of Merger dated as of 3/25/97 (the 'Merger Agreement'), between PHAMIS, Inc.
('PHAMIS') and IDX Systems Corporation ('IDX'), all options became 100% vested and exercisable immediately prior the Merger. The
Effective Time of the Merger was July 10, 1997 and all options became exercisable as of that date.
(4)
Pursuant to the terms of the Merger Agreement, the purchase price per share of IDX Common Stock is determined by dividing the
purchase price per share of PHAMIS Common Stock subject to the PHAMIS option by the Conversion Ratio. For example, the reporting
person was granted options for PHAMIS stock on 01/25/96 at a purchase price of $24.00 ($24.00/.73 = $32.88)
</FN>
</TABLE>
SIGNATURE OF REPORTING PERSON
/S/ By: Robert W. Baker, Jr., Attorney-in-Fact
For: Frank T. Sample
DATE
